AU7687896A - Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags) - Google Patents

Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)

Info

Publication number
AU7687896A
AU7687896A AU76878/96A AU7687896A AU7687896A AU 7687896 A AU7687896 A AU 7687896A AU 76878/96 A AU76878/96 A AU 76878/96A AU 7687896 A AU7687896 A AU 7687896A AU 7687896 A AU7687896 A AU 7687896A
Authority
AU
Australia
Prior art keywords
gags
glycosaminoglycans
dosages
targeting
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU76878/96A
Other versions
AU727001B2 (en
Inventor
Stefan Gustafson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002164260A external-priority patent/CA2164260C/en
Priority claimed from CA 2173037 external-priority patent/CA2173037A1/en
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of AU7687896A publication Critical patent/AU7687896A/en
Application granted granted Critical
Publication of AU727001B2 publication Critical patent/AU727001B2/en
Assigned to JAGOTEC AG reassignment JAGOTEC AG Alteration of Name(s) in Register under S187 Assignors: HYAL PHARMACEUTICAL CORPORATION
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU76878/96A 1995-12-01 1996-11-29 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (GAGS) Ceased AU727001B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA2164260 1995-12-01
CA002164260A CA2164260C (en) 1995-12-01 1995-12-01 Targeting of dosages of medicines and therapeutic agents
CA2173037 1996-03-29
CA 2173037 CA2173037A1 (en) 1996-03-29 1996-03-29 Targeting of dosages of medicines and therapeutic agents and other glycosaminoglycans (gags)
PCT/CA1996/000793 WO1997020564A1 (en) 1995-12-01 1996-11-29 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)

Publications (2)

Publication Number Publication Date
AU7687896A true AU7687896A (en) 1997-06-27
AU727001B2 AU727001B2 (en) 2000-11-30

Family

ID=25678243

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76878/96A Ceased AU727001B2 (en) 1995-12-01 1996-11-29 Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (GAGS)

Country Status (11)

Country Link
EP (1) EP0869798A1 (en)
JP (1) JP2000513707A (en)
KR (1) KR19990071628A (en)
AU (1) AU727001B2 (en)
BR (1) BR9611671A (en)
HU (1) HUP9901935A3 (en)
IL (1) IL124647A0 (en)
MX (1) MX9804343A (en)
NO (1) NO982441L (en)
PL (1) PL326970A1 (en)
WO (1) WO1997020564A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD940054A1 (en) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl SULPHATED POLYSACCHARIDES
CN100374163C (en) 1999-01-13 2008-03-12 阿尔凯米亚肿瘤学私人有限公司 Composition and method for the enhancement of the efficacy of drugs
AUPQ879500A0 (en) 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
WO2007012133A1 (en) * 2005-07-27 2007-02-01 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
MY149606A (en) 2005-09-07 2013-09-13 Alchemia Oncology Pty Ltd Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
AUPM714794A0 (en) * 1994-07-29 1994-08-18 International Fluid Separation Pty Limited Separation apparatus and method
AU3159595A (en) * 1994-08-30 1996-03-22 Hyal Pharmaceutical Corporation Hyaluronic acid and derivatives for modulation of cellular activity

Also Published As

Publication number Publication date
NO982441D0 (en) 1998-05-28
MX9804343A (en) 1998-09-30
BR9611671A (en) 1999-12-28
KR19990071628A (en) 1999-09-27
HUP9901935A2 (en) 1999-11-29
HUP9901935A3 (en) 2001-04-28
AU727001B2 (en) 2000-11-30
WO1997020564A1 (en) 1997-06-12
PL326970A1 (en) 1998-11-09
JP2000513707A (en) 2000-10-17
EP0869798A1 (en) 1998-10-14
NO982441L (en) 1998-05-28
IL124647A0 (en) 1998-12-06

Similar Documents

Publication Publication Date Title
AU6042696A (en) Drug delivery catheters and methods of use
AU4778893A (en) System of drug delivery to the lymphatic tissues
AU5937496A (en) Pericardial therapeutic and diagnostic agent delivery
AU5263496A (en) Targeted catheter drug administration
AU6385396A (en) Drug mitochondrial targeting agents
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
AU6046396A (en) Tricot-like pouch for the delivery of topical drugs and cosm etics
AU3560495A (en) Medicament inhaler
EP0692975A4 (en) Administration of vaso-active agent and therapeutic agent
AP9701092A0 (en) Use of fumagilol and derivateves thereof for preparing medicaments against intestinal infections
EP0745401A3 (en) Inhaler type medicine administering device
AU5945296A (en) Medicament for nasal administration
AU6823696A (en) Acylated derivatives of melatonin and its analogues, useful s medicaments
NZ301231A (en) An optically active (+)-isomer of 2-piperidinylethoxy substituted 4-phenyl-2-benzopyran derivatives and medicaments
PL312064A1 (en) Soft gelatinous form of pharmaceutical dose
AU7294196A (en) Stable pharmaceutical forms of administration containing parathormone
AU5710896A (en) Intrapulmonary delivery of hematopoietic drug
HUP9900147A2 (en) Therapeutic agents and pharmaceutical compositions for treatment of autoimmune diseases
AU7687896A (en) Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
AU1956092A (en) Pharmaceutical agent for treatment of withdrawal symptoms
AU1466097A (en) Protected biopolymers for oral administration and methods of using same
AU1727297A (en) Application of pyrrolidine derivatives to the preparation of medicaments intended to the treatment of drug abuse
ZA9610039B (en) Targeting of dosages of medicine and therapeutic agents and other glycosaminoglycans (gags)
GB9524942D0 (en) Drug therapy
AU6167696A (en) Preparation of immunogens and other conjugates of drugs

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: JAGOTEC AG

Free format text: FORMER OWNER WAS: HYAL PHARMACEUTICAL CORPORATION